Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19
Clinical trial NCT04669015 · UNKNOWN
Trial details
- NCT number
- NCT04669015
- Sponsor
- Genova Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-10
- Primary completion
- 2022-08-01
- Enrollment
- 914
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.